HC
Heron Capital
Venture CapitalActiveHeron Capital is a venture capital fund dedicated to investing in mid and growth stage companies focused on the life sciences, including
11
Investments
4
Exits
$162M
AUM
36.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Heron Capital.
Investment Thesis & Strategy
Heron Capital invests in mid and growth-stage companies within the biotech and fintech industries. They seek companies with strong growth potential and a focus on life sciences.
Investment Activity
Deals per year over the last 7 years
4
20150
20160
20173
20180
20190
20203
2021Portfolio Companies
Selected investments from their portfolio of 11 companies
V
Ventyx Biosciences
Biotech · Series B, 2021
C
Cerevel Therapeutics
Biotech · Growth, 2021
O
Obsidian Therapeutics
Biotech · Series B, 2021
R
Revolution Medicines
Biotech · Series B, 2018
T
Turning Point Therapeutics
Biotech · Series B, 2018
G
Gossamer Bio
Biotech · Series B, 2018
K
Kura Oncology
Biotech · Series B, 2015
M
Mirati Therapeutics
Biotech · Series B, 2015
I
Ignyta
Biotech · Series B, 2015
A
Arvinas
Biotech · Series B, 2015
Frequently Asked Questions
Heron Capital focuses on Series A, Series B, Series C+ stage investments.